EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. - Wikidata - awgldk - TriplyDB

EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.

EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.

http://www.wikidata.org/entity/Q34075391

about

Mutagenic Effects of Iron Oxide Nanoparticles on Biological Cells Nanomaterials and autophagy: new insights in cancer treatment Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity Nanomaterials toxicity and cell death modalities Magnetic nanoparticles as mediators of ligand-free activation of EGFR signaling Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.Interference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1β producing inflammasome.Ferroferric oxide nanoparticles induce prosurvival autophagy in human blood cells by modulating the Beclin 1/Bcl-2/VPS34 complex.Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cells Post-cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspa- se-3-mediated Apoptosis Induction: -Anti-lung cancer potential of Condurango 30C in rats Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles.Biotargeted nanomedicines for cancer: six tenets before you begin Overendocytosis of superparamagnetic iron oxide particles increases apoptosis and triggers autophagic cell death in human osteosarcoma cell under a spinning magnetic field Promising iron oxide-based magnetic nanoparticles in biomedical engineering.Metallomics insights for in vivo studies of metal based nanomaterials.Novel nanoparticulate systems for lung cancer therapy: an updated review.Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells.Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations.Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation.Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges

P2860

Q26782085-E3F44590-35D0-46B4-99B0-705003914F5E Q28386642-A8C4D993-6D53-4AB2-B9BB-3BE2D847C685 Q28388552-78E70798-5868-4452-98A5-2D30B8D9E4A1 Q28392044-07B2BD98-7288-47BA-B037-E5E1340AB5A8 Q28534809-E2727E90-EDD1-4116-A52C-C2E5DD9B9198 Q30461227-707827BE-C42E-4E9D-B803-222291241E6F Q33824400-06E0C31D-6B18-4C20-A9E4-533F3776431F Q34050547-51CED622-EE6D-4604-B6A2-86006A381847 Q34421061-8834A73A-A2C0-4415-AE6F-3D16D0E448AF Q34823550-21DCE53D-40BB-4CF9-85BA-1C1970401922 Q35031165-2536C978-F238-4220-8FF4-15F5CB3887EA Q35093594-10C01098-A05A-4BA0-8EF0-18102A2A847F Q35168522-7F811B2B-E2A8-4C1D-823C-4E134A1637A9 Q36814280-54353139-E5B1-435B-A0FB-94D005F14F3E Q37705979-75FFF404-8A13-4579-B1D8-72B1BF13235A Q38069511-09D77274-D045-4AEC-BA01-46E68CC43F44 Q38115202-E043706D-7419-430A-9BA7-356EC3AA0B54 Q38762917-035E7A19-96C6-4428-A756-8DC96C6B8688 Q39282242-91FFB820-E2E1-4F6D-9633-4D39BAB40E7C Q40064209-2FFA5C41-2037-4BF9-9E62-6731A3785EED Q40176991-675BC310-A807-4A85-AFCD-91069F1597D0 Q42365479-FACDA47A-C3D2-4C63-9E03-700560B1B0D1 Q50127220-A8844C89-52E8-413F-8D5D-9F52EA94B6BC Q50153603-91E2F16A-5B5E-4A65-8911-F61DF8161C03 Q50697137-EE53CE82-A921-4068-B224-AD44F1047BCB Q59019514-FEEC231D-9200-40CC-8BB5-11512F7C731F

P2860

EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.

http://www.wikidata.org/entity/Q34075391

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@ast

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@en

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@nl

type

label

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@ast

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@en

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@nl

prefLabel

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@ast

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@en

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@nl

P1433

Q34075391-ED82E9EE-4AF9-4722-AC9C-BE08AE5E1EC4

P1476

Q34075391-762B5E4B-A7F8-4F63-9CA5-CE0F4F92307A

P2093

Q34075391-27AAE76A-A0A4-4AD9-960D-B7E09B92ADB5

Q34075391-67551050-5A8A-49E0-A6C4-01A95B6A662C

Q34075391-6E65A8A0-E0FD-49DC-9187-5368A5E7A02C

Q34075391-78138661-290C-4A14-997B-1BB792C14698

Q34075391-8BFFF1C2-4D6B-46CD-A815-396072D55937

Q34075391-9ADD07F0-4D7A-4C12-84C4-119653E9F22D

Q34075391-9EB7E8E4-BB9F-4C81-B9FB-A65A91484FD3

Q34075391-C37038A5-744C-4D16-BE13-AA1B518ACAF0

Q34075391-C3953EA1-EA4C-4CB7-B5CD-3F323229C76C

Q34075391-CC96C5D0-2404-4F77-B98E-B880D3557FF6

P2860

Q34075391-086D8492-6EB8-4E1E-9E83-C994CB08D213

Q34075391-0BF47076-DB6C-4229-A028-ED1E0FE85E64

Q34075391-14547A59-4324-4752-AD6B-851662045F86

Q34075391-17FF3840-BB84-4404-91AF-DE1DEA4039BF

Q34075391-1BAB51CF-BB6B-43E3-A035-823942735722

Q34075391-1D2716BC-F815-486A-8006-2C48392B1142

Q34075391-350E838A-E9E7-4226-A6E4-9B9F334494DD

Q34075391-3777CE97-D69C-4CAE-9327-A0CB0B27384E

Q34075391-3B8425E1-F25F-4FB7-AAA1-F734281F6C68

Q34075391-3B9C5F0A-CD0F-47A2-996F-92D0189E7466

P304

Q34075391-A877A057-BCB1-4FD6-BE3F-62C66044DA6E

P31

Q34075391-979CC6A8-73CC-42D7-94D3-45A5382CF541

P356

Q34075391-840006E5-91B6-4B8B-B7D4-13E64A566023

P407

Q34075391-1A20DCEE-C124-4CC6-868D-9886585DA3C3

P433

Q34075391-B2E77013-7973-419E-BF10-6F88C8E41DBB

P478

Q34075391-2FAD6403-BD4E-470B-AA9D-423679F5640C

P50

Q34075391-2FBB3A92-82AA-4384-B2BB-1D6067DF2FED

P577

Q34075391-3E51694B-522F-445A-8BE3-7D3E79175C72

P5875

Q34075391-41196E6F-30BD-4FE8-A2AF-05FF95545E2D

P698

Q34075391-C3E55094-5A70-45DA-A0A6-E24DD2B30B21

P921

Q34075391-17E8DE6F-4E93-40E3-9047-40C83B190676

Q34075391-610D31EB-3714-43F4-9236-BD7C44CBB9D2

Q34075391-B5636C7E-BA80-4B53-BA6C-A406AF307346

P932

Q34075391-EA60DA00-6462-4FFA-AFC8-D531A18AEE6C

P356

JOURNAL.PONE.0025507

P1433

P1476

EGFR-targeted hybrid plasmonic ...... -small cell lung cancer cells.

@en

P2093

Ailing W Scott

http://www.w3.org/2001/XMLSchema#string

Arlene M Correa

http://www.w3.org/2001/XMLSchema#string

Jack A Roth

http://www.w3.org/2001/XMLSchema#string

Jesse Aaron

http://www.w3.org/2001/XMLSchema#string

Justina Tam

http://www.w3.org/2001/XMLSchema#string

Manish Shanker

http://www.w3.org/2001/XMLSchema#string

Rajagopal Ramesh

http://www.w3.org/2001/XMLSchema#string

Seiji Kondo

http://www.w3.org/2001/XMLSchema#string

Shinji Kuroda

http://www.w3.org/2001/XMLSchema#string

Tim Larson

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Quantum dots for live cells, in vivo imaging, and diagnostics

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

How to interpret LC3 immunoblotting

Cancer nanotechnology: opportunities and challenges

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Designing a polyvalent inhibitor of anthrax toxin.

Bifunctional Gold Nanoshells with a Superparamagnetic Iron Oxide-Silica Core Suitable for Both MR Imaging and Photothermal Therapy.

P304

e25507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0025507

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Konstantin Sokolov

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51800408

http://www.w3.org/2001/XMLSchema#string

P698

22087216

http://www.w3.org/2001/XMLSchema#string

P921

magnetic nanoparticles

P932

3210119

http://www.w3.org/2001/XMLSchema#string